Michael T. Andriole

Insider Reports History

Entity
Individual
Location
C/O Endocyte, Inc., 3000 Kent Avenue, Suite A1 100, West Lafayette, IN
Signature
/s/ Michael Alrutz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael T. Andriole:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CHIMERIX INC PRESIDENT AND CEO, Director Common Stock 462K $383K $0.83 Aug 8, 2024 Direct
CHIMERIX INC PRESIDENT AND CEO, Director Stock Option (Right to Buy) 503K Feb 1, 2024 Direct

Insider Reports Filed by Michael T. Andriole

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMRX CHIMERIX INC Aug 8, 2024 1 -$1.06K 4 Aug 9, 2024 PRESIDENT AND CEO, Director
CMRX CHIMERIX INC Feb 14, 2024 1 -$1.81K 4 Feb 16, 2024 PRESIDENT AND CEO, Director
CMRX CHIMERIX INC Feb 1, 2024 2 $0 4 Feb 2, 2024 PRESIDENT AND CEO, Director
CMRX CHIMERIX INC Dec 29, 2023 1 $0 4 Dec 29, 2023 President and CEO, Director
CMRX CHIMERIX INC Aug 1, 2023 2 $29.8K 4 Aug 1, 2023 President and CEO, Director
CMRX CHIMERIX INC May 18, 2023 1 $59.1K 4 May 19, 2023 Chief Business Officer and CFO
CMRX CHIMERIX INC Jan 17, 2023 2 $0 4 Jan 19, 2023 Chief Business Officer and CFO
CMRX CHIMERIX INC Aug 25, 2022 2 $105K 4 Aug 29, 2022 Chief Business Officer and CFO
CMRX CHIMERIX INC May 17, 2022 1 $25.6K 4 May 18, 2022 Chief Business Officer and CFO
CMRX CHIMERIX INC Jan 18, 2022 1 $0 4 Jan 20, 2022 Chief Business Officer and CFO